Company news

Lantheus Holdings, Inc. news in 2025

Lantheus Holdings, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Lantheus to Present Florbetaben F 18 Data at CTAD 2025

November 23, 2025

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

November 5, 2025

Lantheus Announces Leadership Transition Plan

November 5, 2025

Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

October 29, 2025

Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease

October 27, 2025

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8: 00 a.m. Eastern Time

October 22, 2025

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

September 23, 2025

Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

September 1, 2025

Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update

August 6, 2025

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

August 5, 2025

Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8: 00 a.m. Eastern Time

July 22, 2025

Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D

July 21, 2025

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

June 10, 2025

Lantheus to Present at the 2025 Truist Securities MedTech Conference

June 9, 2025

Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

June 2, 2025

PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

June 2, 2025

Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update

May 6, 2025

Lantheus Announces Sale of SPECT Business to SHINE Technologies

May 5, 2025

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

April 29, 2025

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8: 00 a.m. Eastern Time

April 22, 2025

Lantheus Completes Acquisition of Evergreen Theragnostics

March 31, 2025

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

February 25, 2025

Lantheus to Present at Upcoming Investor Conferences

February 20, 2025

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8: 00 a.m. Eastern Time

February 11, 2025

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

February 4, 2025

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

January 29, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

January 27, 2025

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market

January 12, 2025

Calls in 2025

Decks in 2025